Breast Mapping and Detection of Suspicious Breast Lesions Using Feminai
Recruiting
Observational Study
Breast Cancer Awareness
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 25 – 75
- Sex
- Female
- Study type
- Observational
- Participants needed
- 300 (estimated)
- Sponsor
- Feminai · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Prospective observational study evaluating the safety and accuracy of Feminai 1.0, an at-home adhesive patch that measures skin temperature and electrical impedance to map each breast. Up to 300 women (ages 25-75) undergoing screening will have one study visit; Feminai results will be compared with mammography and, when available, biopsy to assess sensitivity and negative predictive value. Feminai…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
General:
1. Females aged 25-75 years.
2. Able to comply with study procedures and follow-up requirements.
3. Willing and able to provide informed consent.
Additional for Group 1 (up to N=150):
1. Presenting for routine mammography/tomosynthesis breast cancer screening accordi…
Contacts
No contact information available.